Literature DB >> 1660470

Vitamin D receptor interaction with specific DNA. Association as a 1,25-dihydroxyvitamin D3-modulated heterodimer.

T Sone1, S Kerner, J W Pike.   

Abstract

The vitamin D receptor (VDR) is a member of the steroid receptor gene family. In this report, we examine the nature of specific VDR DNA binding utilizing the vitamin D-responsive element derived from the human osteocalcin promoter. Association of the VDR with the human osteocalcin 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) responsive element (VDRE) in vitro was characterized on VDRE affinity columns by both weak and strong interactions. Weak interaction was a property of the VDR itself, monomeric in nature, and determined exclusively by the VDR's DNA-binding domain. Strong interaction, in contrast, was dependent upon an intact receptor molecule as well as a heterologous mammalian cell nuclear accessory factor (NAF). Heteromeric interaction between VDR and NAF was independent of the VDR DNA-binding domain, suggesting the presence of a functional dimerization domain separate from that for DNA binding. Direct association of NAF with immobilized VDR revealed that the interaction does not require the presence of DNA. Most importantly, while occupancy of the VDR by 1,25(OH)2D3 was not required for VDR interactions with either DNA or NAF, the presence of hormone increased the apparent relative affinity of the VDR for NAF approximately 10-fold. These studies suggest that high affinity association of the VDR with DNA requires both the DNA-binding domain as well as an additional independent structure located within the steroid-binding region. This protein subdomain interacts with NAF and is regulated by 1,25(OH)2D3.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660470

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA.

Authors:  Igor Orlov; Natacha Rochel; Dino Moras; Bruno P Klaholz
Journal:  EMBO J       Date:  2011-12-16       Impact factor: 11.598

2.  1,25-Dihydroxyvitamin D3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1beta production.

Authors:  S Peleg; H Qiu; S Reddy; D Harris; Q Van; E H Estey; M Talpaz; Z Estrov
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 3.  Biology and Mechanisms of Action of the Vitamin D Hormone.

Authors:  J Wesley Pike; Sylvia Christakos
Journal:  Endocrinol Metab Clin North Am       Date:  2017-09-29       Impact factor: 4.741

4.  Detection of 1α,25-dihydroxyvitamin D-regulated miRNAs in zebrafish by whole transcriptome sequencing.

Authors:  Theodore A Craig; Yuji Zhang; Andrew T Magis; Cory C Funk; Nathan D Price; Stephen C Ekker; Rajiv Kumar
Journal:  Zebrafish       Date:  2014-03-20       Impact factor: 1.985

5.  Functionality of unliganded VDR in breast cancer cells: repressive action on CYP24 basal transcription.

Authors:  Fatouma Alimirah; Avani Vaishnav; Michael McCormick; Ibtissam Echchgadda; Bandana Chatterjee; Rajendra G Mehta; Xinjian Peng
Journal:  Mol Cell Biochem       Date:  2010-05-04       Impact factor: 3.396

6.  Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts.

Authors:  L A Crofts; M S Hancock; N A Morrison; J A Eisman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  Identification of a vitamin D responsive element in the promoter of the rat cytochrome P450(24) gene.

Authors:  C N Hahn; D M Kerry; J L Omdahl; B K May
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

8.  Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins.

Authors:  S R Patel; H Q Ke; R Vanholder; R J Koenig; C H Hsu
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers.

Authors:  B Cheskis; L P Freedman
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

10.  Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene.

Authors:  P N MacDonald; D R Dowd; S Nakajima; M A Galligan; M C Reeder; C A Haussler; K Ozato; M R Haussler
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.